Diantha Duvall - Net Worth and Insider Trading

Diantha Duvall Net Worth

The estimated net worth of Diantha Duvall is at least $223,405 dollars as of 2024-06-21. Diantha Duvall is the Chief Accounting Officer of Bioverativ Inc and owns about 2,128 shares of Bioverativ Inc (BIVV) stock worth over $223,397. Diantha Duvall is also the CHIEF FINANCIAL OFFICER of Genocea Biosciences Inc and owns about 76,743 shares of Genocea Biosciences Inc (GNCAQ) stock worth over $8. Details can be seen in Diantha Duvall's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Diantha Duvall has not made any transactions after 2022-05-26 and currently still holds the listed stock(s).

Transaction Summary of Diantha Duvall

To

Diantha Duvall Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Diantha Duvall owns 4 companies in total, including Genocea Biosciences Inc (GNCAQ) , Bioverativ Inc (BIVV) , and Curis Inc (CRIS) among others .

Click here to see the complete history of Diantha Duvall’s form 4 insider trades.

Insider Ownership Summary of Diantha Duvall

Ticker Comapny Transaction Date Type of Owner
GNCAQ Genocea Biosciences Inc 2022-05-26 CHIEF FINANCIAL OFFICER
BIVV Bioverativ Inc 2018-03-08 Chief Accounting Officer
CRIS Curis Inc 2023-01-20 CFO
LIMIT LIMIT 2019-03-05 CHIEF FINANCIAL OFFICER

Diantha Duvall Latest Holdings Summary

Diantha Duvall currently owns a total of 2 stocks. Among these stocks, Diantha Duvall owns 2,128 shares of Bioverativ Inc (BIVV) as of June 28, 2017, with a value of $223,397 and a weighting of 100%. Diantha Duvall also owns 76,743 shares of Genocea Biosciences Inc (GNCAQ) as of May 26, 2022, with a value of $8 and a weighting of 0%.

Latest Holdings of Diantha Duvall

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BIVV Bioverativ Inc 2017-06-28 2,128 104.98 223,397
GNCAQ Genocea Biosciences Inc 2022-05-26 76,743 0.00 8

Holding Weightings of Diantha Duvall


Diantha Duvall Form 4 Trading Tracker

According to the SEC Form 4 filings, Diantha Duvall has made a total of 0 transactions in Bioverativ Inc (BIVV) over the past 5 years. The most-recent trade in Bioverativ Inc is the sale of 818 shares on June 28, 2017, which brought Diantha Duvall around $49,465.

According to the SEC Form 4 filings, Diantha Duvall has made a total of 2 transactions in Genocea Biosciences Inc (GNCAQ) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Genocea Biosciences Inc is the sale of 24,407 shares on May 26, 2022, which brought Diantha Duvall around $1,953.

Insider Trading History of Diantha Duvall

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Diantha Duvall Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Diantha Duvall Ownership Network

Ownership Network List of Diantha Duvall

No Data

Ownership Network Relation of Diantha Duvall

Insider Network Chart

Diantha Duvall Owned Company Details

What does Genocea Biosciences Inc do?

Who are the key executives at Genocea Biosciences Inc?

Diantha Duvall is the CHIEF FINANCIAL OFFICER of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , director & President and CEO William D Clark , and 10 percent owner New Enterprise Associates 16, L.p. .

Genocea Biosciences Inc (GNCAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Genocea Biosciences Inc Insider Transactions

No Available Data

Diantha Duvall Mailing Address

Above is the net worth, insider trading, and ownership report for Diantha Duvall. You might contact Diantha Duvall via mailing address: C/o Genocea Biosciences, Inc., 100 Acorn Park Drive 5th Floor, Cambridge Ma 02140.

Discussions on Diantha Duvall

No discussions yet.